Cargando…

Editorial: Despite COVID-19, Pharmaceutical Innovation Marches On!

Detalles Bibliográficos
Autor principal: Scypinski, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424125/
https://www.ncbi.nlm.nih.gov/pubmed/32837608
http://dx.doi.org/10.1007/s12247-020-09481-x
_version_ 1783570273968062464
author Scypinski, Stephen
author_facet Scypinski, Stephen
author_sort Scypinski, Stephen
collection PubMed
description
format Online
Article
Text
id pubmed-7424125
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-74241252020-08-13 Editorial: Despite COVID-19, Pharmaceutical Innovation Marches On! Scypinski, Stephen J Pharm Innov Editorial Springer US 2020-08-13 2020 /pmc/articles/PMC7424125/ /pubmed/32837608 http://dx.doi.org/10.1007/s12247-020-09481-x Text en © Springer Science+Business Media, LLC, part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Editorial
Scypinski, Stephen
Editorial: Despite COVID-19, Pharmaceutical Innovation Marches On!
title Editorial: Despite COVID-19, Pharmaceutical Innovation Marches On!
title_full Editorial: Despite COVID-19, Pharmaceutical Innovation Marches On!
title_fullStr Editorial: Despite COVID-19, Pharmaceutical Innovation Marches On!
title_full_unstemmed Editorial: Despite COVID-19, Pharmaceutical Innovation Marches On!
title_short Editorial: Despite COVID-19, Pharmaceutical Innovation Marches On!
title_sort editorial: despite covid-19, pharmaceutical innovation marches on!
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424125/
https://www.ncbi.nlm.nih.gov/pubmed/32837608
http://dx.doi.org/10.1007/s12247-020-09481-x
work_keys_str_mv AT scypinskistephen editorialdespitecovid19pharmaceuticalinnovationmarcheson